The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Multiple Functions of Endocannabinoid Signaling in the Brain
Open accessAbstract
Despite being regarded as a hippie science for decades, cannabinoid research has finally found its well-deserved position in mainstream neuroscience. A series of groundbreaking discoveries revealed that endocannabinoid molecules are as widespread and important as conventional neurotransmitters such as glutamate or GABA, yet they act in profoundly unconventional ways. We aim to illustrate how uncovering the molecular, anatomical, and physiological characteristics of endocannabinoid signaling has revealed new mechanistic insights into several fundamental phenomena in synaptic physiology. First, we summarize unexpected advances in the molecular complexity of biogenesis and inactivation of the two endocannabinoids, anandamide and 2-arachidonoylglycerol. Then, we show how these new metabolic routes are integrated into well-known intracellular signaling pathways. These endocannabinoid-producing signalosomes operate in phasic and tonic modes, thereby differentially governing homeostatic, short-term, and long-term synaptic plasticity throughout the brain. Finally, we discuss how cell type– and synapse-specific refinement of endocannabinoid signaling may explain the characteristic behavioral effects of cannabinoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is widely accepted28 that CCK-positive cells in the rodent show selectively high expression of cannabinoid receptors and are involved in perisomatic inhibition.”
From Transcriptomic and morphophysiological evidence for a specialized human cortical GABAergic cell type (2018) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,182
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“1C-D) (Devane et al., 1988; Bidaut-Russell et al., 1990).”
BackgroundIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Research works printed but not linked: 1
- Gaoni Y, 1967, Tetrahedron Lett., 12, 1109
Cited by
Sorted by citations
Items 401–500 of 675
Suleymanova, E. M., Karan, A. A., Borisova, M. A., Volobueva, M. N., & Bolshakov, A. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076509 · Cited by 7
Martín-Llorente, A., Serrano, M., Río, I. B., Lekunberri, L., Ocerin, G., Puente, N., Ramos, A., Rico‐Barrio, I., Gerrikagoitia, I., & Grandes, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417316 · Cited by 7
The Perspective of Cannabidiol in Psoriasis Therapy
Stănescu, A. M. A., Bejan, G. C., Baltă, M. D., Andronic, O., Toma, C. V., & Busnatu, Ș. (2024) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s469698 · Cited by 7
Veeraraghavan, P., & Nistri, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.045 · Cited by 7
Neurochemical Communication: The Case of Endocannabinoids
Heinbockel, T. (2014) · InTech eBooks · doi:10.5772/58410 · Cited by 7
Blair, R. E., Deshpande, L. S., & DeLorenzo, R. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00006-0 · Cited by 7
The Neuropathology of Drug Abuse
Büttner, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00007-1 · Cited by 7
The intraocular pressure-lowering properties of intravenous paracetamol
van den Heever, H., & Meyer, D. (2016) · Clinical ophthalmology · doi:10.2147/opth.s87988 · Cited by 7
Salazar, I. B., Elezgarai, I., Rico‐Barrio, I., Gerrikagoitia, I., Puente, N., & Grandes, P. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24808 · Cited by 7
Do the effects of cannabis on the hippocampus and striatum increase risk for psychosis?
Daniju, Y., Bossong, M. G., Brandt, K. R., & Allen, P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.010 · Cited by 7
Cannabis and Complex Posttraumatic Stress Disorder
Dagan, Y., & Yager, J. (2020) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001172 · Cited by 7
Baggelaar, M. P., Janssen, F. J., van Esbroeck, A. C. M., den Dulk, H., Allarà, M., Hoogendoorn, S., McGuire, R., Florea, B. I., Meeuwenoord, N. J., van den Elst, H., et al. (2013) · Angewandte Chemie · doi:10.1002/ange.201306295 · Cited by 7
Pentylenetetrazol-induced seizure-like behavior and neural hyperactivity in the medicinal leech
Hahn, E., & Burrell, B. D. (2015) · Invertebrate Neuroscience · doi:10.1007/s10158-014-0177-1 · Cited by 7
Jorgensen, M. M., & Burrell, B. D. (2022) · Journal of Comparative Physiology A · doi:10.1007/s00359-021-01540-z · Cited by 7
de Oliveira, F. R., da Silva, N. M., Hamoy, M., Lopez, M. E. C., Ferreira, I. M., da Silva, E. O., Macchi, B. D. M., & do Nascimento, J. L. M. (2022) · Molecules · doi:10.3390/molecules27113595 · Cited by 7
Insights Into the Pathophysiology of Endocannabinoid Signaling in Schizophrenia
Volk, D. W., & Lewis, D. A. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0844 · Cited by 7
CB1 receptor signaling: Linking neuroplasticity, neuronal types, and mental health outcomes
Gao, Q., & Asim, M. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105938 · Cited by 6
Haddad, N. M., de Jesus, L. P., Serpa, M. H., van de Bilt, M. T., Talib, L. L., Costa, A. C., Gattaz, W. F., & Loch, A. A. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01788-x · Cited by 6
CB1 receptors in NG2 cells mediate cannabinoid-evoked functional myelin regeneration
de la Torre, A. S., Ezquerro, S., Huerga-Gómez, A., Sánchez-Martín, E., Chara, J. C., Matute, C., Monory, K., Mato, S., Lutz, B., Guzmán, M., et al. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102683 · Cited by 6
Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy
Montebello, G., & Giovanni, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136234 · Cited by 6
Lipids IN the brain: Crossing the “insurmountable” barrier for a fatty, happy life
Fabiani, E. D. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400260 · Cited by 6
Vielma, A. H., Tapia, F., Alcaino, A., Fuenzalida, M., Schmachtenberg, O., & Chávez, A. E. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.3.3 · Cited by 6
Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB1) Receptor
Horváth, V. B., Soltész‐Katona, E., Wisniewski, É., Rajki, A., Halász, E., Enyedi, B., Hunyady, L., Tóth, A. D., & Szanda, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.740913 · Cited by 6
Vecchiarelli, H. A., Aukema, R. J., Hume, C., Chiang, V., Morena, M., Keenan, C. M., Nastase, A. S., Lee, F. S., Pittman, Q. J., Sharkey, K. A., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.764706 · Cited by 6
Introductory Chapter: Mechanisms and Function of Synaptic Plasticity
Heinbockel, T. (2017) · InTech eBooks · doi:10.5772/67891 · Cited by 6
Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS
Kouchaeknejad, A., van der Walt, G., de Donato, M. H., & Puighermanal, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115829 · Cited by 6
Whole-body biodistribution of the cannabinoid type 1 receptor ligand [ 18 F]MK-9470 in the rat
Buchholz, H., Uebbing, K., Maus, S., Pektor, S., Afahaene, N., Weyer‐Elberich, V., Lutz, B., Schreckenberger, M., & Miederer, I. (2017) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2017.06.003 · Cited by 6
Miederer, I., Buchholz, H., Kronfeld, A., Maus, S., Weyer‐Elberich, V., Mildenberger, P. C., Lutz, B., & Schreckenberger, M. (2017) · Medical Physics · doi:10.1002/mp.12732 · Cited by 6
Ferreira, T. A. A., Areal, L. B., Herlinger, A. L., Paiva, K. K., Cicilini, M. A., Martins-Silva, C., & Pires, R. G. W. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112231 · Cited by 6
Laricchiuta, D., Balsamo, F., Fabrizio, C., Panuccio, A., Termine, A., & Petrosini, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031072 · Cited by 6
FATTY ACIDS AS CELL SIGNALS IN INGESTIVE BEHAVIORS
Figlewicz, D. P., & Witkamp, R. F. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112985 · Cited by 6
Silva, M. H., & Kwok, R. K. (2022) · Current Research in Toxicology · doi:10.1016/j.crtox.2022.100064 · Cited by 6
Xiao, J., Zhou, Y., Sun, L., & Wang, H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1152167 · Cited by 6
The Endocannabinoid System in the Control of Behavior
Gómez, E. S., Metna‐Laurent, M., Bellocchio, L., Busquets-García, A., & Marsicano, G. (2017) · Wiley eBooks · doi:10.1002/9781118540770.ch13 · Cited by 6
Bosch, B. M., Bringard, A., Logrieco, M. G., Lauer, E., Imobersteg, N., Thomas, A., Ferretti, G., Schwartz, S., & Iglói, K. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/211227 · Cited by 6
Вячеславовна, С. М., Kuznetsova, G. D., Sysoev, I. V., Ngomba, R. T., Vinogradova, L. V., Grishchenko, A. A., van Rijn, C. M., & van Luijtelaar, G. (2023) · Epilepsy Research · doi:10.1016/j.eplepsyres.2023.107135 · Cited by 5
Muzik, O., Mann, T., Kopchick, J. J., Chowdury, A., Yacou, M. A., Vadgama, J., Bonello, D., & Diwadkar, V. A. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100035 · Cited by 5
Fifty years of ‘cannabinoid research’ and the need for a new nomenclature
Marzo, V. D., & PETROCELLIS, L. D. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch8 · Cited by 5
Kronfeld, A., Buchholz, H., Maus, S., Reuss, S., Müller‐Forell, W., Lutz, B., Schreckenberger, M., & Miederer, I. (2015) · Medical Physics · doi:10.1118/1.4934825 · Cited by 5
STORM Super-Resolution Imaging of CB1 Receptors in Tissue Preparations
Zöldi, M., & Katona, I. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_36 · Cited by 5
Self-citationRegulation of Presynaptic Release Machinery by Cell Adhesion Molecules
Uchigashima, M., Hayashi, Y., & Futai, K. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-34229-5_13 · Cited by 5
Endocannabinoid Signaling and Synaptic Plasticity During Stress
Gray, J. M., Vecchiarelli, H. A., & Hill, M. N. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1056-4_6 · Cited by 5
Cannabis, Cannabinoide und das Endocannabinoidsystem
Schneider, M., Hoch, E., Simon, R., Pfeiffer-Gerschel, T., Kraus, L., Häuser, W., & Lutz, B. (2018) · Springer eBooks · doi:10.1007/978-3-662-57291-7_1 · Cited by 5
Zorigt, O., Yasuda, H., Nakajima, T., & Tsushima, Y. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1622-24.2025 · Cited by 4
Neural and Behavioral Correlates Associated with Adolescent Marijuana Use
Subramaniam, P., & Yurgelun-Todd, D. A. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00335-7 · Cited by 4
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_2 · Cited by 4
Lifespan changes in cannabinoid 1 receptor mRNA expression in the female C57BL/6J mouse brain
Li, X., Zhao, G., Huang, H., Ye, J., Xu, J., Zhou, Y., Zhu, X., Wang, L., & Wang, F. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25427 · Cited by 4
The Endocannabinoid System in Human Physiology
Chianese, R., & Meccariello, R. (2016) · InTech eBooks · doi:10.5772/63818 · Cited by 4
Chronic cannabis use affects cerebellum dependent visuomotor adaptation
Blithikioti, C., Miquel, L., Paniello-Castillo, B., Nuño, L., Gual, A., Ballester, B. R., Fernandez, A., Herreros, I., Verschure, P. F. M. J., & Balcells-Olivero, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.007 · Cited by 4
Cannabinoids and Endocannabinoids
Jung, K., & Piomelli, D. (2015) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_136-1 · Cited by 4
Cannabinoid Receptors and Their Signaling Mechanisms
Basavarajappa, B. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809666-6.00002-2 · Cited by 4
Pedro, J. R., Moura, L. I. F., Valério-Fernandes, Â., Baptista, F. I., Gaspar, J. M., Pinheiro, B. S., Lemos, C., Kaufmann, F. N., Morgado, C., da Silva-Santos, C. S., et al. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.05.004 · Cited by 4
Electrophysiology of Endocannabinoid Signaling
Musella, A., & Centonze, D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_38 · Cited by 4
Ren, S., Sun, Z., & Yang, J. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.01.004 · Cited by 4
Mikkelsen, J. D., Aripaka, S. S., Eğilmez, C. B., & Pazarlar, B. A. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105717 · Cited by 4
Cannabinoids and Endocannabinoids
Jung, K., & Piomelli, D. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3474-4_136 · Cited by 4
Yin, T., Sun, S., Peng, L., Yang, M., Li, M., Yang, X., Yuan, F., Zhu, H., & Wang, S. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02202-2 · Cited by 3
(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Åkesson, A., Bampidis, V., Bignami, M., Chipman, J. K., Degen, G. H., Hernández, A. F., Hofer, T. P., Högstrand, C., et al. (2025) · EFSA Journal · doi:10.2903/j.efsa.2025.9735 · Cited by 3
Meza, R. C., Morales-Weil, K., Ancatén-González, C., Escobar, A. P., Alcaino, A., Sanguinetti, N. K., Delpire, E. J., Moya, P. R., Chiu, C. Q., Fuenzalida, M., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02364-8 · Cited by 3
Mušić, T., & Turnšek, T. L. (2026) · Biomedicines · doi:10.3390/biomedicines14050968 · Cited by 3
Endocannabinoids and Dopamine Balance Basal Ganglia Output
Gorodetski, L., Loewenstern, Y., Faynveitz, A., Bar‐Gad, I., Blackwell, K. T., & Korngreen, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.639082 · Cited by 3
Reactive spinal glia convert 2-AG to prostaglandins to drive aberrant astroglial calcium signaling
Dócs, K., Balázs, A., Papp, I., Szűcs, P., & Hegyi, Z. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1382465 · Cited by 3
Janthakhin, Y., Juntapremjit, S., Hummel, K., Razzazi‐Fazeli, E., & Kingtong, S. (2024) · Bioinformatics and Biology Insights · doi:10.1177/11779322241306290 · Cited by 3
Morozov, Y. M., & RAKIC, P. T. (2025) · iScience · doi:10.1016/j.isci.2025.113188 · Cited by 3
Witkamp, R. F. (2014) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-06151-1_9 · Cited by 3
Taketo, M., & Matsuda, H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.022 · Cited by 3
Endocannabinoid-Mediated Synaptic Plasticity
Mackie, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_2 · Cited by 3
Pavón, F. J., Polis, I. Y., Stouffer, D. G., Roberto, M., Martin‐Fardon, R., de Fonseca, F. R., Parsons, L. H., & Serrano, A. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14456 · Cited by 3
Pirri, F., Akbarabadi, A., Sadat‐Shirazi, M., Zadeh‐Tehrani, S. N., Mahboubi, S., Goudarzi, A. K., & Zarrindast, M. (2021) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10094 · Cited by 3
Vural, İ. M., Fincan, G. S. Ö., Koç, D., Okcay, Y., Askin, C. I., Güzin, A. K. K., İlhan, S. Ö., & Sarıoğlu, Y. (2022) · PubMed Central · doi:10.22038/ijbms.2022.62222.13772 · Cited by 3
Zada, W., Murtaza, G., Iqbal, G., Abbas, G., Khan, S. A., & Mannan, A. (2022) · Sains Malaysiana · doi:10.17576/jsm-2022-5110-22 · Cited by 3
Physiology of the endocannabinoid system: Imaging and the use of positron emission tomography (PET)
Poluga, C., Varlow, C., Vasdev, N., Boileau, I., & Best, L. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00011-5 · Cited by 3
Inhibitors of cannabinoid receptor 1 suppress the cellular entry of Lujo virus
Kimura, M., Matsuoka, R., Taniguchi, S., Maruyama, J., Paessler, S., Oka, S., Yamashita, A., Fukuhara, T., Matsuura, Y., & Tani, H. (2023) · Virology · doi:10.1016/j.virol.2023.109867 · Cited by 3
Vered, S., Beiser, A., Sulimani, L., Sznitman, S. R., Gonzales, M. M., Aparicio, H. J., DeCarli, C. S., Scott, M. R., Ghosh, S., Lewitus, G. M., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01301-x · Cited by 3
Molecular mechanisms for targeted treatments in fragile X syndrome
Miranda, I., & Hagerman, R. J. (2023) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2023.21 · Cited by 3
Interactions between physical exercise, associative memory, and genetic risk for Alzheimer’s disease
Iglói, K., Bosch, B. M., Kuenzi, N., Thomas, A., Lauer, E., Bringard, A., & Schwartz, S. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae205 · Cited by 3
Pakkhesal, S., Shakouri, M., Mosaddeghi-Heris, R., Kiani-Nasab, S., Salehi, N., Sharafi, A., & Ahmadalipour, A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108799 · Cited by 3
Bubbico, G., Tomaiuolo, F., Sestieri, C., Akhlaghipour, G., Granzotto, A., Ferretti, A., Perrucci, M. G., Sensi, S. L., & Pizzi, S. D. (2025) · Brain and Behavior · doi:10.1002/brb3.70565 · Cited by 3
Hooper, J., Williams, S. L., Mueller, R. L., & Hutchison, K. E. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2727016 · Cited by 3
Age-Dependent Effects of Cannabinoids on Neurophysiological, Emotional, and Motivational States
Viveros, M., & Marco, E. M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_11 · Cited by 3
Shimizu, T., Tanaka, K., Shimizu, S., Higashi, Y., Yawata, T., Nakamura, K., Taniuchi, K., Ueba, T., Yuri, K., & Saito, M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.034 · Cited by 3
From “Azalla” to Anandamide: Distilling the Therapeutic Potential of Cannabinoids
Radhakrishnan, R., & Ross, D. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.017 · Cited by 3
Special issue editorial: Cannabinoid signalling in the brain: New vistas
Busquets-García, A., Melis, M., Bellocchio, L., & Marsicano, G. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15618 · Cited by 3
Distinct endocannabinoids specifically signal to astrocytes and neuronsPreprint
Noriega‐Prieto, J. A., Falcón‐Moya, R., Eraso‐Pichot, A., Fundazuri, U. B., Guttipatti, P., Belisle, L., Moreno, A. R., van der Stelt, M., Cheer, J. F., Marsicano, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.13.544877 · Cited by 3
Piovesana, R., Charron, S., Arbour, D., Marsicano, G., Bellocchio, L., & Robitaille, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.12.575382 · Cited by 3
Cairus, A., Brizolara, F., Kunizawa, H., Clouzet, V., Gonzalez, G., Alsina‐Llanes, M., Dellepiane, L., Fernández, S., García‐Carnelli, C., Umpiérrez, E., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70153 · Cited by 2
Li, C., Ma, J., Huang, G., Chen, B., Chengwei, H. E., & Wu, R. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70388 · Cited by 2
Endocannabinoid Modulation in Headache: Mechanisms, Models, and Translational Therapies
Wen, J., & Zhang, Y. (2026) · Cells · doi:10.3390/cells15040331 · Cited by 2
Brain-body integromics of the ayahuasca experience
Madrid-Gambín, F., Mallaroni, P., Haro, N., Pozo, Ó. J., Mason, N. L., Reckweg, J. T., Kloft, L., van Oorsouw, K. I. M., Toennes, S. W., & Ramaekers, J. G. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119391 · Cited by 2
Mack, D., Yevugah, A., Renner, K. J., & Burrell, B. D. (2022) · Journal of Experimental Biology · doi:10.1242/jeb.243404 · Cited by 2
The therapeutic use of cannabis in South Africa: panacea or scourge?
Maule, W. J. (2022) · Journal of Medical Laboratory Science & Technology of South Africa · doi:10.36303/jmlstsa.2022.4.1.93 · Cited by 2
Dudek, K., Paton, S. E. J., Collignon, A., Lebel, M., Lavoie, O., Bouchard, J., Kaufmann, F. N., Dion‐Albert, L., Clavet-Fournier, V., Binder, L. B., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.02.012 · Cited by 2
Neonatal dysregulation of 2-arachidonoylglycerol induces impaired brain function in adult mice
Boo, K.-J., Kim, D., Cho, E., Kim, D. H., Jeon, S. J., & Shin, C. Y. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110045 · Cited by 2
Holzhausen, E. A., Tan, Y., Young, N., Jones, R. B., Tang, Z., Sarnat, J. A., Lurmann, F., Chang, H. H., Tran, V., Jones, D. P., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c04955 · Cited by 2
Brain Imaging of Cannabinoid Receptors
Casteels, C., Bormans, G. M., & Laere, K. V. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00003-8 · Cited by 2
Sysoev, I. V., Perescis, M. F. J., Vinogradova, L. V., Вячеславовна, С. М., & van Rijn, C. M. (2018) · Russian Open Medical Journal · doi:10.15275/rusomj.2018.0404 · Cited by 2
Introductory Chapter: The Chemical Basis of Neural Function and Dysfunction
Heinbockel, T., & Csoka, A. B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89072 · Cited by 2
Balancing the Neuroprotective Versus Neurotoxic Effects of Cannabis
Mouli, S., Ramesh, S., Govindarajulu, M., Almaghrabi, M., Fujihashi, A., Nadar, R. M., Salamat, J. M., DeRuiter, J., Clark, R. C., Moore, T., et al. (2021) · Springer eBooks · doi:10.1007/978-981-33-4141-8_8 · Cited by 2
Wood, C. P., Avalos, B., Alvarez, C., & DiPatrizio, N. V. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0150 · Cited by 2
WITHDRAWN: The Endocannabinoid System: Overview of an Emerging Multi-faceted Therapeutic Target
Chanda, D., Neumann, D., & Glatz, J. F. C. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.07.004 · Cited by 2
Retracted
Metadata
- Authors
- Katona, I., & Freund, T. F.
- Affiliations
- HUN-REN Institute of Experimental Medicine (HU)
- Venue
- Annual Review of Neuroscience
- Publisher
- Annual Reviews
- Published
- 2012-07-21
- Volume
- 35
- Issue
- 1
- Pages
- 529-558
- ISSN
- 0147-006X (ISSN-L)
- 1545-4126
- PMC
- PMC4273654
- OpenAlex
- W2168499817
- Cited by
- 630
- References
- 183
- Citations by year
- 2026: 39 · 2025: 35 · 2024: 29 · 2023: 44 · 2022: 53 · 2021: 60 · 2020: 56 · 2019: 32 · 2018: 50 · 2017: 57 · 2016: 34 · 2015: 45 · 2014: 43 · 2013: 41 · 2012: 11
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annual Review of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (090946)
- National Institute of Mental Health (R01MH054671, MH54671)
- National Institute of Neurological Disorders and Stroke (R37NS030549, R01NS030549, NS30549)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- endocannabinoid signaling, anandamide, 2-arachidonoylglycerol, signalosome, synaptic plasticity, intracellular signaling, cell type-specific signaling, brain
- MeSH terms
- Animals, Arachidonic Acids, Behavior, Animal, Brain, Glycerides, Humans, Ligands, Models, Neurological, Synaptic Transmission, Neuronal Plasticity, Signal Transduction, Receptors, Cannabinoid, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review